C1q-Binding HLA Antibodies Do Not Predict Platelet Transfusion Failure in TRAP Study Participant

被引：0
|
作者：
Jackman, Rachael P. [1 ]
Bolgiano, Douglas [2 ]
Lebedeva, Mila [1 ]
Slichter, Sherrill J. [2 ,3 ]
Norris, Philip J. [1 ,4 ]
机构：
[1] Blood Syst Res Inst, San Francisco, CA USA
[2] Puget Sound Blood Ctr, Seattle, WA 98104 USA
[3] Univ Washington, Sch Med, Seattle, WA USA
[4] Univ Calif San Francisco, San Francisco, CA 94143 USA
来源：
BLOOD | 2014年 / 124卷 / 21期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [21] Role of C1q-binding donor-specific anti-HLA antibodies in Premature and Accelerated Kidney Allograft Interstitial Fibrosis
    Louis, Kevin
    Viglietti, Denis
    Aubert, Olivier
    Loupy, Alexandre
    Lefaucheur, Carmen
    TRANSPLANTATION, 2018, 102 : S276 - S276
  • [22] The Clinical Usefulness of Preformed C1q-Binding Donor-Specific Antibodies in Kidney Transplantation
    Lee, S.
    Ko, E.
    Chung, B.
    Yang, C.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2020, 20 : 848 - 848
  • [23] Role of C1q-Binding Donor-Specific Anti-HLA Antibodies in Premature and Accelerated Kidney Allograft Interstitial Fibrosis.
    Louis, K.
    Viglietti, D.
    Aubert, O.
    Loupy, A.
    Lefaucheur, C.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2018, 18 : 442 - 442
  • [24] Effect of Complement Inhibition Therapy (Eculizumab) in Patients with C1q-Binding Donor-Specific Anti-HLA Antibodies: A Molecular Appraisal
    Lefaucheur, C.
    Hidalgo, L.
    Reeve, J.
    Viglietti, D.
    Gosset, C.
    Aubert, O.
    Ulloa, C.
    Legendre, C.
    Glotz, D.
    Halloran, P.
    Loupy, A.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2016, 16 : 273 - 273
  • [25] Effect of complement inhibition therapy (eculizumab) in patients with C1q-binding donor-specific anti-HLA antibodies: A molecular appraisal
    Lefaucheur, Carmen
    Hidalgo, Luis
    Reeve, Jeff
    Viglietti, Denis
    Gosset, Clement
    Aubert, Olivier
    Ulloa, Camilo
    Legendre, Christophe
    Glotz, Denis
    Halloran, Philip
    Loupy, Alexandre
    TRANSPLANTATION, 2016, 100 (07) : S417 - S417
  • [26] The prevalence and clinical significance of C1q-binding donor-specific anti-HLA antibodies early and late after kidney transplantation
    Calp-Inal, Sumeyye
    Ajaimy, Maria
    Melamed, Michal L.
    Savchik, Christina
    Masiakos, Peter
    Colovai, Adriana
    Akalin, Enver
    KIDNEY INTERNATIONAL, 2016, 89 (01) : 209 - 216
  • [27] Successful Eradication of De Novo C1q-Binding Donor-Specific Antibodies with Rituximab Monotherapy
    Moghbeli, K.
    Xu, Q.
    Zeevi, A.
    Morrell, M.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2021, 40 (04): : S508 - S508
  • [28] Characterization of the C1q-Binding Ability and the IgG1-4 Subclass Profile of Preformed Anti-HLA Antibodies by Solid-Phase Assays
    Navas, Ana
    Molina, Juan
    Aguera, Maria-Luisa
    Guler, Ipek
    Jurado, Aurora
    Rodriguez-Benoto, Alberto
    Alonso, Corona
    Solana, Rafael
    FRONTIERS IN IMMUNOLOGY, 2019, 10 : 1712
  • [29] Anti-HLA Donor-Specific IgG Subclasses and C1q-binding Evolution in Posttransplant Monitoring
    Ponsirenas, Renata von Glehn
    Cazarote, Helena B.
    Araujo, Stanley de Almeida
    Wanderley, David Campos
    Shimakura, Silvia
    Valdameri, Joana S.
    Contieri, Fabiana L. C.
    von Glehn, Cristina C. Q. C.
    Susin, Michelle F.
    Sotomaior, Vanessa Santos
    TRANSPLANTATION DIRECT, 2018, 4 (09):
  • [30] Kidney Transplantation with Strong Preformed Donor-Specific Antibodies: Impact of C1q-Binding Ability
    Malheiro, J.
    Tafulo, S.
    Santos, S.
    Costa, M.
    Martins, L.
    Dias, L.
    Henriques, A.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2016, 16 : 706 - 706
12345